Researchers have described the development of a novel murine model of glioblastoma established with a patient-derived xenograft (PDX) in humanized mice that harbored an almost complete human immune ...

Cecile Richards, a prominent advocate for women's rights and other progressive causes and former President of Planned ...

GAITHERSBURG, Md. - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), a specialty pharmaceutical company with a current ...

The Phase 2 trial is conducted at Georgetown University Medical Center, Allegheny Health Network (AHN) Cancer Institute, UNC Medical Center, the UVA Cancer Center, John Theurer Cancer Center at ...

Sativex could become one of the first additions to NHS treatment for glioblastoma patients since temozolomide chemotherapy in 2007. At the moment Jazz is directed its in-house development ...

Glioblastoma Multiforme [GBM] is characterized ... which in turn bodes well for the next phase of development. Speaking of which, this is going to include the company moving forward with the ...

Dr. Chen is developing a new delivery system which is designed to help cancer drugs cross the blood-brain barrier.